297
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

The utility of CD200 expression and modified Matutes score in the diagnostic differentiation of mantle cell lymphoma and chronic lymphocytic leukemia using flow cytometry

ORCID Icon, , &
Pages 504-506 | Received 16 Apr 2019, Accepted 29 Aug 2019, Published online: 27 Sep 2019

References

  • Kelemen K, Peterson LC, Helenowski I, et al. CD23+ mantle cell lymphoma: a clinical pathologic entity associated with superior outcome compared with CD23- disease. Am J Clin Pathol. 2008;130(2):166–177.
  • Palumbo GA, Parrinello N, Fargione G, et al. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Leuk Res. 2009;33(9):1212–1216.
  • Sandes AF, de Lourdes Chauffaille M, Oliveira CR, et al. CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry. Cytometry B Clin Cytom. 2013;86(2):98–105.
  • Lesesve JF, Tardy S, Frotscher B, et al. Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms. Int Jnl Lab Hem. 2015;37(4):486–494.
  • Challagundla P, Medeiros LJ, Kanagal-Shamanna R, et al. Differential expression of CD200 in B-cell neoplasms by flow cytometry can assist in diagnosis, subclassification, and bone marrow staging. Am J Clin Pathol. 2014;142(6):837–844.
  • Alapat D, Coviello-Malle J, Owens R, et al. Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma. Am J Clin Pathol. 2012;137(1):93–100.
  • Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8(10):1640–1645.
  • D’Arena G, Vitale D, Rossi G, et al. CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia. Haematol Oncol. 2018;36:543–546.
  • Kohnke T, Wittmann VK, Bucklein VL, et al. Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200. Br J Haematol. 2017;179(3):480–487.
  • Mora A, Bosch R, Cuellar C, et al. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia. Cytometry B Clin Cytom. 2019;96(2):143–148.
  • Demir C, Kara E, Ekinci O, et al. Clinical and laboratory features of CD5-negative chronic lymphocytic leukemia. Med Sci Monit. 2017;23:2137–2142.
  • Soleimani A, Tanios G, Safah H, et al. A systematic review of CD5-negative mantle cell lymphoma identifies potential clinical and biological implications. Blood. 2016;128(22):3048.
  • Rawstron AC, Kreuzer KA, Soosapilla A, et al. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: an European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) harmonisation project. Cytometry B Clin Cytom. 2018;94(1):121–128.
  • Dorfman DM, Shahsafaei A. CD200 (OX-2 membrane glycoprotein) expression n b cell-derived neoplasms. Am J Clin Pathol. 2010;134(5):726–733.
  • Fan L, Miao Y, Wu YJ, et al. Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis. Leuk Lymphoma. 2015;56(12):3329–3335.
  • Dasgupta A, Ramani M, Mehrotra V, et al. CD200 expression in B-chronic lymphocytic leukemia-it is not an all or none phenomenon. Cytometry B Clin Cytom. 2013;84(6):406.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.